#United States #Durham, NC #Alcami Corporation #Durham NC #Biologics Industry

Alcami Corporation's Expansion in Durham, NC

Alcami Corporation, a prominent player in the contract development and manufacturing organization (CDMO) space, has announced a substantial expansion of its laboratory services at its facility on Creekstone Drive in Durham, North Carolina. This strategic move is aimed at addressing the escalating demand in the biologics market, ensuring that Alcami continues to lead in providing integrated solutions across the pharmaceutical and biotech landscapes.

The expansion spans 20,000 square feet and is projected to be completed by 2026, marking a significant investment in enhancing Alcami’s analytical capabilities. These upgrades will focus on supporting a range of biologics, including peptides, oligonucleotides, antibody-drug conjugates (ADCs), and cell and gene therapy (CGT) products. The advanced laboratory will feature cutting-edge technology in bioseparation, mass spectrometry, electrophoresis, and bioassay methodologies, enabling Alcami to deliver precise method establishment, release, and stability testing services.

Commitment to Excellence

Katie Schlipp, President of Laboratory Services at Alcami, emphasized the company's dedication to promoting scientific excellence and innovation through this investment. She stated, "By expanding our capabilities, we're enabling our clients to bring life-changing therapies to patients with greater speed and scalability." This commitment not only highlights Alcami's role in the pharmaceutical supply chain but also its focus on operational agility, which is essential in today's rapidly evolving healthcare landscape.

The Creekstone Drive facility is a vital part of Alcami's extensive network of laboratory, manufacturing, and pharmaceutical storage locations across the United States. This broad network allows Alcami to integrate laboratory services seamlessly with its drug product manufacturing and storage solutions, providing clients with an efficient and bundled sourcing option for their needs.

Strategic Enhancements Across the Network

The expansion in Durham aligns with Alcami's recent investments at its other facilities, including increased sterile fill-finish capacities in RTP and Charleston and enhanced oral solid dose capabilities in Wilmington, NC. These developments underscore Alcami's strategic approach to reinforcing its facilities in response to the growing demand in the pharmaceutical sector, ensuring that the company is well-positioned to meet future challenges and opportunities.

For more information about Alcami's comprehensive laboratory services and their impact on drug development, you can visit their website at Alcami Lab Services.

About Alcami

Founded over 45 years ago, Alcami Corporation is dedicated to advancing pharmaceutical and biologic products from development through to delivery. As a privately owned entity, Alcami is backed by investment firms such as GHO Capital, The Vistria Group, and Ampersand Capital Partners. Their expertise spans lab services, drug product manufacturing, and cGMP pharma storage, making them an increasingly valuable partner in the biotech and pharmaceutical industries. For further details, please check out Alcami Official Site.